Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Ip Group Share News (IPO)
IPO Share
Price
IPO Share
News
IPO Share
Chat
IPO Share
Trades214
IPO
Live RNS
IPO Share
Charts
IPO Level 2
Console
IPO Live
Share Price
IPO Broker
Ratings
IPO Directors
Deals
IPO Financial
Diary
IPO
Fundamentals
IPO Short
Positions
IPO
Media
IPO Company
Research
IPO Company
Timeline
Share Price Information for Ip Group (IPO)
Last checked at -
Last checked at 
Intraday Ip Group Share Chart
Avacta Non-Executive Sam Williams Steps Down After General Meeting
(Alliance News) - Avacta Group PLC on Monday said Sam Williams is stepping down from his role as a non-executive director with immediate effect.
Williams joined the biotechnology company at the end of January, keeping his role of chief executive of life sciences at investment firm IP Group PLC.
"The chairman and board would like to thank Sam for his contribution and look forward to continuing to work with Sam in his role at IP Group as a strongly supportive investor in Avacta," the company said in its statement Monday.
Avacta shares closed 1.9% lower on Monday in London at 15.70 pence each.
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
Latest IPO News
- IP Group rejects "final" takeover proposal from Railpen
23 Jun 2026 - IP Group says Railpen proposal 'materially undervalued' the company
23 Jun 2026 - LONDON MARKET CLOSE: Pound holds firm as PM Starmer says to stand down
22 Jun 2026 - IP Group rejects takeover proposal from Railways Pension Trustee Company
22 Jun 2026 - IP Group rejects GBP615.8 million takeover proposal from Railpen
22 Jun 2026 - IP Group investee Istesso starts phase 2 arthritis trial of leramistat
16 Jun 2026 - IP Group portfolio company begins dosing patients in Phase 2 trial
16 Jun 2026 - UK shareholder meetings calendar - next 7 days
11 Jun 2026
Related News
TRADING UPDATES: Avacta appoints "seasoned" new deputy chair
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by A...
EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
Avacta agrees design of pivotal US cancer therapy trial
(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...
Ip Group News
IP Group rejects "final" takeover proposal from Railpen
(Alliance News) - IP Group PLC on Tuesday confirmed that it recently received an acquisition proposal from Railways Pension Trustee Co Ltd through its...
IP Group says Railpen proposal 'materially undervalued' the company
(Sharecast News) - IP Group confirmed on Tuesday that it has rejected a takeover proposal from shareholder Railways Pension Trustee Company, or Railpe...
LONDON MARKET CLOSE: Pound holds firm as PM Starmer says to stand down
(Alliance News) - The FTSE 100 rose on Monday, and the pound made headway, as UK Prime Minister Keir Starmer confirmed he was stepping down and as tal...
IP Group rejects takeover proposal from Railways Pension Trustee Company
(Sharecast News) - Railways Pension Trustee Company (Railpen) said on Monday that IP Group has rejected a takeover proposal of up to 74.7p per share.
IP Group rejects GBP615.8 million takeover proposal from Railpen
(Alliance News) - Railways Pension Trustee Company Ltd, or Railpen, on Monday said IP Group PLC has rejected its possible takeover offer worth GBP615....
IP Group investee Istesso starts phase 2 arthritis trial of leramistat
(Alliance News) - IP Group PLC on Tuesday announced that portfolio company Istesso has commenced dosing for the IST-03 trial of leramistat in sarcopen...
IP Group portfolio company begins dosing patients in Phase 2 trial
(Sharecast News) - Science and technology investment firm IP Group said on Tuesday that portfolio company Istesso has begun dosing patients in a Phase...
Follow the stocks
